Patents by Inventor Min Yung Lee

Min Yung Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230180459
    Abstract: A method for forming a thin film structure may include providing a TiN member, forming a MoO2 thin film on the TiN member by using a first ALD (atomic layer deposition) process using ozone (O3) as a reactant, and forming a TiO2 thin film having a rutile crystal structure on the MoO2 thin film by using a second ALD process. The MoO2 thin film may have a thickness of about 10 nm or less. A TiO2 element layer may be further formed between the TiN member and the MoO2 thin film. The TiO2 element layer may have a nanodot array shape or a continuous layer structure. The TiO2 thin film may have a dielectric constant of 100 or more. The method of manufacturing a capacitor may further include forming a conductive material layer on the TiO2 thin film.
    Type: Application
    Filed: December 6, 2022
    Publication date: June 8, 2023
    Inventors: Min Yung Lee, Woojin Jeon, Yewon Kim
  • Publication number: 20130113071
    Abstract: A semiconductor device includes a fuse configured to be programmed in response to a laser, a protective layer formed under the fuse and overlapping with a portion of the fuse, and a heat emission portion coupled with the protective layer.
    Type: Application
    Filed: September 14, 2012
    Publication date: May 9, 2013
    Inventor: Min-Yung LEE
  • Publication number: 20110098360
    Abstract: Disclosed is a pharmaceutical composition containing a compound useful for inhibiting neurotoxicity caused by beta amyloid. The pharmaceutical composition of the present disclosure contains 1,3,5,7-tetrakis(aminomethyl)adamantane, an analogous compound thereof or a salt thereof as an active ingredient. The inventors have studied methods for reducing the toxicity of beta amyloid oligomers based on the formation mechanism of dodecamers in consideration of the fact that especially the dodecamers from among the beta amyloid oligomers exhibit a significant activity as a toxin for synapses and neurons in cranial nerve diseases. The inventors have confirmed that the disclosed compound can induce structural epitope deformation of the dodecamer and thereby reduce toxicity of the beta amyloid oligomers.
    Type: Application
    Filed: March 9, 2009
    Publication date: April 28, 2011
    Applicant: NANODIAMOND, INC.
    Inventors: Min Yung Lee, So-Yeop Han, Jun Mo Chung, Pyung Lim Han, Jung Min Koh, Ha Yan Oak, Eun Kyung Hwang, In Sun Baek
  • Publication number: 20100298600
    Abstract: Disclosed herein is a method for chemically attaching carboxyl, alcohol, amine or amide groups to the surface of nanodiamond (ND) in a liquid phase. Also disclosed herein are a functional ND compound obtained by the method and use thereof. The method includes treating synthetic ND with a size of 1 nm-1OO nm with sonication and a strong acid to provide ND-(COOH)n. The ND-(COOH)n compound is used as a starting material to provide ND compounds having alcohol, amine or amide groups attached to the surfaces thereof. The surface-functionalized ND compounds are characterized by using an X-ray diffractometer, FTIR, AFM, particle size analyzer and zeta sizer. The ND compounds show functionalities as well as high solubility to provide stable ND solutions in a liquid phase. Therefore, the ND compounds may be used as diamond coating agents. The powder of the ND compounds may be used as materials for producing composites of polymers, plastics, synthetic fibers, ceramics, etc.
    Type: Application
    Filed: October 9, 2008
    Publication date: November 25, 2010
    Applicant: NANODIAMOND INC.
    Inventor: Min Yung Lee